Regulatory Pathways for Parametric Release
Posted on December 18, 2022
Marla Stevens-Riley, Branch Chief in Division of Microbiology Assessment, FDA
Parametric Release and Pharmaceutical Manufacturing Manufacturing flexibility, better process understanding, and optimal manufacturing control are desirable goals for the pharmaceutical industry. There are a variety of ways in which firms can achieve these goals, and the development of a parametric ...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy















